Extranodal lymphoma: A comparative study

Hematology

Volumn 13, Issue 3, 2008, Pages 163-169

  AlShemmari, Salem H ^a   Ameen, Reem M ^a   Sajnani, Kamlesh P ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b Department of Medical Oncology   (Kuwait)

Author keywords

Extranodal lymphoma; Features; Outcome

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ARAB; ARTICLE; ASIAN; B CELL LYMPHOMA; BRAIN LYMPHOMA; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; INTESTINE LYMPHOMA; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; STOMACH LYMPHOMA; TREATMENT OUTCOME;

ARABS; ASIAN CONTINENTAL ANCESTRY GROUP; CENTRAL NERVOUS SYSTEM NEOPLASMS; GASTROINTESTINAL NEOPLASMS; HUMANS; KUWAIT; LYMPHOMA, EXTRANODAL NK-T-CELL; LYMPHOMA, NON-HODGKIN; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 55849108477     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453308X316149     Document Type: Article

References (29)

1. Groves FD, Linet MS, Travis LB. Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtypes in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92: 1240-1251.
2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33-64.
3. Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992; 52 (Suppl.): S5432-S5440.
4. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727-737.
5. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites. Ann Oncol 1999: 8: 1023-1033.
6. Weisenburger DD. Epidemiology of non-Hodgkin's lymphoma: Recent findings regarding an emerging epidemic. Ann Oncol 1994; 5 (Suppl. 1): S19-S24.
7. Public Authority for Civil Information (PACI). Directory of civil information; regulations and labor force. Kuwait city: PACI, 2003.
8. Al-Shemmari SH, Sajnani KP, Ameen RM, Ragheb AM. Primary gastrointestinal non-Hodgkin's lymphoma: Treatment outcome. Clin Lymphoma 2003; 4 (2): 99-103.
9. WHO classification of Tumors: Pathology and genetics of tumors: haematopoietic and lymphoid tissues. Lyon: 1ARC Press; 2001.
10. Carbone PP, Kaplan HS, Musshoff K et al. Report of the Committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1861.
11. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909-3918.
12. Rosenberg SA. Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. Cancer Treat Rep 1977; 61: 1023-1027.
13. Musshoff K. Classification of the clinical stages of non-Hodgkin's lymphoma. Strahlentherapie 1977; 153: 218-221.
14. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252-260.
15. Gospodarowicz MK, Sutcliffe SB. The extranodal lymphomas. Semin Radia Oncol 1995; 5: 281-300.
16. Paryani S, Hoppe RT, Burke JS et al. Extralymphatic involvement indiffuse non-Hodgkin's lymphoma. J Clin Oncol 1983; 1: 682-688.
17. Rudders RA, Ross ME, DeLellis RA. Primary extranodal lymphorna: Response to treatment and factors influencing prognosis. Cancer 1978; 42: 406-416.
18. d'Amore F, Christensen BE, Brincker H et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer 1991; 27: 1201-1208.
19. Economopoulos T, Asprou N, Stathakis N et al. Primary extranodal non- Hodgkin's lymphoma in adults: Clinicopathological and survival characteristics. Leuk Lymphoma 1996; 21: 131-136.
20. Zucca E, Roggero E, Bertoni F et al. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727-737.
21. Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: A study of 117 cases presenting with gastrointestinal disease. Cancer 1978; 42: 693-707.
22. Glass AG, Karnell LH, Menck HR. The National Cancer Data Base report on non-Hodgkin's lymphoma. Cancer 1997; 80: 2311-2320.
23. Levine P, Hoover RN. The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiologic factors. Cancer Res 1992; 2 (Suppl.): S542S-S5474.
24. Otter R, Gerrits WB, Sandt MM et al. Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol 1989; 25: 1203-1210.
25. Krol ADG, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Primary extranodal non-Hodgkin's lymphoma (NHL): The impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Annals of Oncology 2003; 14: 131-139.
26. Gronbaek K, Thor Straten P, Ralfkiaer E et al. Somatic Fas mutations in non- Hodgkin's lymphoma: Association with extranodal disease and autoimmunity. Blood 1998; 92: 3018-3024.
27. Rao PH, Houldsworth J, Dyomina K et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 1998; 92: 234-240.
28. Moller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation - a population-based study of 1575 cases. Br J Haematol 2004; 124: 151-159.
29. Gospodarowicz MK, Sutcliffe SB, Brown TC et al. Patterns of disease in localized extranodal lymphomas. J Clin Oncol 1987; 5: 875-880.